100
Participants
Start Date
September 5, 2017
Primary Completion Date
September 13, 2019
Study Completion Date
September 13, 2019
OSU 6162
All patients will receive a dose of OSU6162 15 mg BID x 2 per day. The expected duration of therapy is 12 weeks. After 1 week of treatment, patients who do not respond to treatment will have their dose increased to maximum 30 mg BID x 2 per day.
Placebo Oral Tablet
All patients will receive a dose of placebo 15 mg BID x 2 per day. The expected duration of therapy is 12 weeks. After 1 week of treatment, patients who do not respond to treatment will have their dose increased to maximum 30 mg BID x 2 per day.
Oslo University Hospital, Oslo
Göteborg University
OTHER
Sahlgrenska University Hospital
OTHER
Oslo University Hospital
OTHER